News and Announcements
As one of the top five pharmaceutical companies in Australia, Wyeth plays an important role in the provision of quality treatments that improve the health and wellbeing of Australians.
Wyeth has developed clear positions on a range of current healthcare issues such as reform of the Pharmaceutical Benefits Scheme and ensuring Australians have information about, and timely access to, the latest innovative treatments for themselves and their families.
News and Announcements
March 13, 2007- Wyeth Builds on Commitment to Innovation in Haemophilia
March 13, 2007- Wyeth Seeks to Further Its Innovation in Haemophilia
August 11, 2006- Government approves treatment for people living with debilitating skin & joint disease
February 24, 2006- Warning on looming health crisis: Infectious Disease Specialist
February 20, 2006- Infant formula manufacturers welcome Pru Goward
Fast Facts
- Currently more than 100 million women around the world take the pill.
- Between one quarter to one third of all occurrences of Haemophilia appear in families with no previous history .
- Most obstetricians and other health care professionals agree that a weight gain of about 12 to 14 kg is optimal during pregnancy for most women of average weight and height.




